I once had hopes of becoming an astronaut, but if Elite: Dangerous for the Xbox One serves as any indication, it’s probably a good thing that little dream didn’t pan out. I spent around 20 minutes crashing into hulls before I managed to dock my ship. I overshot my destinations in space more times than I care to count. I spent five minutes blasting space barrels without even being sure if I was doing it right. And that was just the tutorial. In the actual game, Elite: Dangerous offers a massive galaxy with around 400 billion stars, all bursting with dogfights, piracy, trading opportunities, and undiscovered planets — not to mention light years of dull nothingness. Few other games so brilliantly capture the vastness of space; fewer still have mechanics so complex they inadvertently emph…

By Anand James  

Last week, we had placed two bets going into the shortened week. That upside would be limited to 23580-680 in Nifty and that there would be a mean reversion move. While the former turned to be spot on to the dot, the mean reversion expectations failed to mature fully, despite several attempts to head lower. 

Reasons could be several, including the shortened nature of the week, as well as low VIX. What we are keen on pondering is how they are likely to shape the fate of the next week. VIX, which had been on a steep fall since the electoral outcome, rose in a couple of days, but the rise was too feeble to expand trading ranges.

Nifty’s supports have held so far

We are te…

Dabur’s stock price saw a 2% increase on Friday following the company’s announcement of strong earnings for the fourth quarter of FY24. Improved sales volume and the positive impact of a price hike contributed to the rise. Dabur shares climbed by 2.51% to reach Rs 537.50 each on the BSE.

In the quarter ending March 2024, Dabur India reported a consolidated net profit of Rs 341.22 crore, marking a 16.5% increase from Rs 292.76 crore in the corresponding quarter of the previous year. Whereas the FMCG giant’s revenue increased by 5.11% to Rs 2,814.64 crore from Rs 2,677.80 crore, YoY.

Friday’s gains followed Dabur’s board approval for share buyback and the release of its March quarter earnings. This marks Ajanta Pharma’s fourth sh…